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Pluripotent stem cells (PSCs) were derived from early embryos as embryonic stem cells (ESCs)1,2 and subsequently from somatic cells via transcription factor-mediated reprogram-
ming3. Murine PSCs are thought to represent a naive pluripotent 
state, characterized by the expression of the transcription factors 
Oct4, Sox2, Nanog, Klf4 and Tfcp2l1 in response to the cytokine LIF 
and the inhibition of GSK3 and MEK kinases4,5. Murine naive PSCs 
display low levels of repressive epigenetic modification, such as tri-
methylation of lysine 9 on histone 3 (H3K9me3) or cytosine meth-
ylation, and are metabolically sustained by high levels of oxidative 
phosphorylation4,5. Importantly, murine naive PSCs efficiently gen-
erate cells of all three germ layers.
Conversely, conventional human PSCs, either derived from 
early embryos2 or via the reprogramming of somatic cells using 
OSKM3, resemble a distinct, more advanced developmental 
stage called primed pluripotency. Primed PSCs express OCT4, 
SOX2 and NANOG in response to fibroblast growth factor (FGF) 
and transforming growth factor-β signals, display higher levels 
of repressive epigenetic modifications and are mostly glycolytic4. 
Different primed PSC lines display a differentiation bias towards 
some germ layers6.
Recently, human naive PSCs have been generated through 
either the expression of transgenes together with genomic reporter 
constructs or directly from human embryos5,7. The use of human 
embryos has ethical limitations and obviously does not allow the 
generation of patient-specific naive PSCs. Meanwhile, the conver-
sion of somatic cells to naive pluripotency using available protocols 
requires one or more rounds of stable genetic manipulations, which 
are time-consuming, inefficient and potentially mutagenic. To over-
come such limitations, we derived a strategy for the efficient genera-
tion of transgene-free niPSCs directly from somatic cells.
Results
Devising a strategy for the transgene-free generation of niPSC 
colonies. We have previously shown that the delivery of modi-
fied messenger RNAs (mmRNAs) encoding for OSKM, LIN28 
and NANOG using microfluidics results in the rapid and efficient 
generation of primed iPSCs8. Here, we compared the global gene 
expression profile of primary iPSC colonies generated via microflu-
idics or under conventional culture conditions (CCC) and observed 
that several transcription factors associated with naive pluripotency 
were upregulated (Fig. 1a,b). This result suggests that microfluidics 
could favour activation of the naive network. Therefore, we deter-
mined whether naive PSCs could be derived directly from primary 
somatic cells using a microfluidics approach. To test this hypothesis, 
we transfected BJ human fibroblasts with mmRNAs via microfluid-
ics using our previously described setup8 (Supplementary Fig. 1a), 
leaving out the primed pluripotency factor LIN28 (that is, using 
OSKMN)9. DPPA5, a gene highly induced in human naive cells10,11, 
became detectable from day 14 (Supplementary Fig. 1b), despite 
the use of FGF2-containing medium for generating primed PSCs 
(that is, primed reprogramming medium (PRM)). The generated 
colonies showed the morphology of primed PSCs and lost DPPA5 
expression after passaging. We then tried to sustain the expression 
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Induced pluripotent stem cells (iPSCs) are generated via the expression of the transcription factors OCT4 (also known as 
POU5F1), SOX2, KLF4 and cMYC (OSKM) in somatic cells. In contrast to murine naive iPSCs, conventional human iPSCs are in 
a more developmentally advanced state called primed pluripotency. Here, we report that human naive iPSCs (niPSCs) can be 
generated directly from fewer than 1,000 primary human somatic cells, without requiring stable genetic manipulation, via the 
delivery of modified messenger RNAs using microfluidics. Expression of the OSKM factors in combination with NANOG for 12 
days generates niPSCs that are free of transgenes, karyotypically normal and display transcriptional, epigenetic and metabolic 
features indicative of the naive state. Importantly, niPSCs efficiently differentiate into all three germ layers. While niPSCs can 
be generated at low frequency under conventional conditions, our microfluidics approach enables the robust and cost-effective 
production of patient-specific niPSCs for regenerative medicine applications, including disease modelling and drug screening.
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Fig. 1 | Devising a strategy for the transgene-free generation of naive-like iPSCs. a, Primary colonies of primed iPSCs generated in wells (CCC) or via 
microfluidics and mmRNAs underwent differential expression analysis8. b, The analysis revealed an increased expression of naive-associated markers 
in microfluidic conditions compared to CCC. Mean ±  s.e.m., n =  4 biological replicates, shown as circles. c, OSKMN-specific mmRNA transfection in the 
presence of PRM led to the formation of primed human iPSC colonies at day 14 (D14; bottom, left panel), expressing DPPA5 (black bar of middle panel; see 
also Supplementary Fig. 1b). Exposure of primary colonies to 2iL transiently upregulated DPPA5 expression (grey bars) but did not lead to the formation 
of naive-like iPSCs. GAPDH served as the loading control. Bars indicate the mean ±  s.e.m. of n =  3 biologically independent experiments, shown as circles. 
Unpaired two-tailed Mann–Whitney U-test. d, Evaluation of the effect of different inhibitors during the first 6 days in PRM. CHIR99021 (CH) promotes 
colony formation and facilitates efficient transfection (Supplementary Fig. 1d). Black bars indicate the means of technical replicates (n =  9 for untreated, 
n =  7 for all other conditions) pooled from 2 independent experiments, shown in two different colours. PD, PD0325901. e, Fibroblast reprogramming using 
PRM+ CHIR99021 for 6 days followed by 2iLGo+ KSR. Fibroblasts convert from a spindle to an epithelial-like morphology (D5). Cells become progressively 
compact and small colonies emerge (arrowheads). Representative pictures of eight independent experiments. f, Immunostaining of primary naive-like 
colonies at D15 reveals expression of naive markers and an absence of SSEA4. Representative pictures of three independent experiments. g,h, Addition 
of a ROCK inhibitor (Ri) and hypoxia increased both the success rate (g) and efficiency (h) of reprogramming. For g, each bar indicates the success 
rate of each independent experiment, calculated as the percentage of technical replicates (numbers above bars) containing naive-like colonies. For h, 
circles indicate technical replicates, whose number is shown in panel g. Black bars indicate the means of technical replicates pooled from independent 
experiments. Kruskal–Wallis test. See also Supplementary Fig. 1f. Scale bars 200 µ m (c, e), 10 µ m (f). Images from additional repeats for panels e and f 
have been deposited in Figshare under DOI: 10.6084/m9.figshare.7151777. See Supplementary Table 5 for all individual numerical values.
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of DPPA5 by providing the correct signalling environment. The 
cytokine LIF, the GSK3 inhibitor CHIR99021 and the MEK inhibi-
tor PD0325901 in N2B27 medium (2iL) are present in several media 
for murine and human naive PSC culture5,7. Switching the media 
to 2iL at day 14 boosted and maintained DPPA5 expression for the 
subsequent 8 days (Fig. 1c). However, they were morphologically 
indistinguishable from colonies kept in PRM (Fig. 1c, bottom pan-
els), and rapidly collapsed upon passaging in 2iL. We reasoned that 
by day 14 in PRM, iPSCs have already lost the competence to reach 
the naive state, so we exposed cells to 2iL from the beginning of 
the reprogramming protocol (Supplementary Fig. 1c). However, 
no iPSC colonies formed, and we observed fibroblast senescence, 
reduced transfection efficiency and failure to execute the mesen-
chymal-to-epithelial transition (MET)12, which normally occurs by 
day 6 (Supplementary Fig. 1c,d).
Based on these observations, we devised a two-step protocol. We 
used PRM for the first 6 days to avoid senescence and allow MET 
and subsequently applied 2iL supplemented with the PKC inhibi-
tor Gö6983 (2iLGo) and 1% knockout serum replacement (KSR), 
which has previously been used to enhance and stabilize human 
naive pluripotency10,11,13 (Fig. 1d, top panel). During the first 6 days, 
we also tested the effect of adding various inhibitors; we observed 
the formation of several naive-like colonies under different combi-
nations, with the most efficient condition being PRM+ CHIR99021 
(Fig. 1d, bottom panel). Under these conditions, mmRNA trans-
fection was robust (Supplementary Fig. 1e), MET occurred by day 
5 and was followed by the appearance of naive-like colonies from 
day 9 (Fig. 1e, red arrowheads). Such colonies expressed the naive 
markers TFCP2L1, DPPA3 and DNMT3L (Fig. 1f), the core factor 
NANOG and were negative for the primed surface maker SSEA414. 
The protocol appeared robust given that 89% of 213 individual 
microfluidic channels presented naive-like colonies (Fig. 1g,h, red), 
representing an efficiency of 0.87% (that is, 0.87 colonies generated 
for 100 fibroblasts seeded). Inhibition of Rho-associated protein 
kinase (ROCK) and hypoxic conditions15,16 resulted in the genera-
tion of colonies in 100% of the microfluidic channels, representing 
an increased efficiency of 3.02% (Fig. 1g,h, purple). We conclude 
that delivering OSKMN-specific mmRNAs via microfluidics facili-
tates the rapid and robust generation of naive PSC colonies from 
human fibroblasts.
Long-term expansion and characterization of naive iPSCs. 
Different media and extracellular matrix proteins have been used for 
the culture of human naive cells5,7. Cells transfected with OSKMN 
were cultured via microfluidics under conditions of hypoxia for 6 
days in PRM+ CHIR99021+ ROCK inhibition (Ri), followed by 
6 days in different naive media, such as 4iLA17 or the commercially 
available RSeT (Fig. 2a). Naive colonies, expressing OCT4 and 
KLF17, formed robustly in all types of media (Fig. 2b; Supplementary 
Fig. 1g), with an increase in colony size in RSeT medium (Fig. 2c,d). 
Coating the microfluidic channels with fibronectin, Matrigel or 
laminin facilitated the generation of naive colonies with comparable 
efficiency (Supplementary Fig. 1g,h), indicating that our protocol 
can be easily adapted to different culture conditions. Next, we tested 
whether primary colonies could be expanded long term. To do so, 
we transferred them from microfluidic conditions to CCC on feed-
ers in the respective media and under hypoxia and we succeeded 
in expanding them over multiple passages (Fig. 2e,f,h). RSeT again 
appeared to be the most robust among the three types of media, so 
it was used for all further experiments.
niPSCs, either freshly derived (passage 0) or after several pas-
sages (up to passage 21), displayed robust expression of naive plu-
ripotency markers. Moreover, they exhibited a strongly reduced 
expression of the differentiation marker T and of the primed plu-
ripotency markers SSEA4, OTX2 and ZIC2, indicating that a stable 
naive phenotype was achieved (Fig. 2e–h; Supplementary Fig. 2a). 
We also obtained niPSCs from four other somatic cells: human 
male foreskin fibroblasts (HFFs), female lung fibroblasts (WI-38 
and IMR-90) and primary skin fibroblasts of an 80-year-old female 
donor (Fig. 2i; Supplementary Fig. 2b–d; Supplementary Table 1). 
All these niPSC lines expressed naive markers and expanded 
robustly over multiple passages, retaining naive morphology and 
high clonogenicity (Fig. 2e,f,j,k; Supplementary Fig. 3a,b).
Some human naive PSC lines, derived from embryos or from 
primed PSCs, display chromosomal instability after extensive cul-
ture11,14,18. Using DNA staining followed by flow cytometry, we 
observed that all lines were diploid for the first 8 passages. A stable 
diploid karyotype was observed in 6 out of 8 lines for up to 42 pas-
sages. Only 2 lines (HPD01 and HPD07) showed a fraction of tet-
raploid cells after 12 and 23 passages, respectively (Supplementary 
Fig. 3c). We isolated the diploid population via fluorescence acti-
vated cell sorting (FACS), and these cells then maintained a correct 
karyotype. A correct karyotype was also confirmed by Q-banding 
in five independent niPSC lines (Fig. 2k; Supplementary Fig. 3d). 
We conclude that reprogramming via microfluidics does not induce 
chromosomal abnormalities per se, which are instead probably due 
to extended culture.
A naive state transcriptome is rapidly acquired during niPSC 
generation. We performed transcriptome profiling of niPSCs, 
primed iPSCs generated via microfluidics (Supplementary Fig. 
1c) and human fibroblasts using RNA-sequencing (RNA-seq). 
Unsupervised clustering based on specific markers grouped niPSCs 
together with other previously described human naive cells10,11,17,18, 
clearly separating them from primed PSCs (Fig. 3a). Similar results 
were obtained by analysing the whole transcriptome (Fig. 3c; 
Supplementary Fig. 4a). Naive iPSCs have been recently gener-
ated from human fibroblasts via Sendai virus-mediated delivery 
of OSKM without a microfluidics approach19,20. Depending on the 
media used, some of those lines grouped together with embryo-
derived naive PSCs and with niPSCs (Fig. 3a,c; Supplementary 
Figs. 4a–c and 8; see also Discussion).
The presence of a unique set of transposable elements expressed 
by cleavage-stage embryos characterize the human naive plu-
ripotent state17. The transposable element profile of niPSCs was 
clearly distinct from those of primed cells and comparable to pre-
viously described naive PSCs (Fig. 3b). Notably, primary colonies 
(“niPSCs p0” in Fig. 3a–c) collected at day 15 were transcriptionally 
indistinguishable from established naive PSCs. We conclude that 
our reprogramming strategy enables the rapid and full acquisition 
of a human naive transcriptome.
Next, we determined whether our system would allow the study 
of the trajectories of iPSC generation from fibroblasts. As proof 
of principle, we transfected fibroblasts with OSKMN-specific 
mmRNAs either under the optimized protocol (described in Fig. 2a) 
to generate niPSCs or in PRM to generate primed iPSCs. A gene 
expression analysis of a panel of naive- and primed-state markers 
revealed that the two reprogramming trajectories diverged signifi-
cantly after day 8 (Fig. 3d,e; Supplementary Fig. 4d). Between days 5 
and 8, cells undergo dramatic morphological changes indicative of 
a MET (Fig. 1e). We measured a reduction in mesenchymal mark-
ers (Fig. 3f, grey) and a gradual activation of epithelial markers 
(Fig. 3f, orange) for both reprogramming protocols, indicating that 
MET is a common early molecular event. We conclude that our 
reprograming method allows the study of distinct trajectories that 
lead to either primed or naive pluripotency.
Global reduction in repressive epigenetic modifications in niPSCs. 
Naive pluripotency is associated with a reduction in repressive 
epigenetic modification, such as H3K9me3 or cytosine methyla-
tion7,10,14,17,18. Immunostaining experiments showed that both mark-
ers were reduced in multiple niPSCs compared to primed PSCs 
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Fig. 2 | Optimized generation and stabilization of the naive phenotype. a, Optimized naive reprogramming setup. b, Effect of different naive media applied 
from D6. Colonies were quantified at D15 either by their compact morphology (green circles) or by the coexpression of KLF17 and OCT4 (red circles). Bars 
indicate the means of technical replicates (circles, n =  28, 15 and 40 replicates for 2iLGo+ KSR+ ROCK inhibition, 4iLA and RSeT, respectively) pooled from  
4 independent experiments, shown in different shades of colours. Kruskal–Wallis test. c, Morphology of representative colonies. d, Quantification of colony size 
as equivalent diameters (Methods). Bars indicate the means of technical replicates (circles, n =  98, 163, 67 and 65 replicates for 2iLGo+ KSR+ ROCK inhibition, 
2iLGo+ KSR+ ROCK inhibition in hypoxia, 4iLA in hypoxia and RSeT in hypoxia, respectively) obtained in 3 independent experiments, shown in different 
colours. Kruskal–Wallis test. e, Gene expression analysis by qPCR of niPSCs, fibroblasts, primed PSCs and reset H9 cells at different passage (p) numbers. A 
significant reduction in naive markers relative to reset H9 cells was observed only in fibroblasts and primed PSCs. f, Reduction in primed pluripotency markers 
in niPSCs. Expression relative to HPD00 primed iPSCs. In both e and f, GAPDH served as the loading control, arrowheads indicate samples with statistical 
significance (unpaired two-tailed Mann–Whitney U-test), bars indicate mean ±  s.e.m. of n =  3 independent experiments, shown as circles. g, Immunostaining 
of all the microfluidic channels at D15. See also Supplementary Fig. 2a. h, Immunostaining for pluripotency and differentiation markers. Representative images 
from 1 out of 2 independent experiments showing consistent results. i, Generation of niPSCs from different somatic cells. Bars indicate the means of technical 
replicates (circles, n =  25, 10, 10 and 4 for HFF-1, WI38, IMR90 and primary XX fibroblasts, respectively) pooled from 3 independent experiments for HFF-1 
and 1 experiment for the other 3 lines. j, Clonal assay of HPD01 niPSCs and reset H9 cells. See Supplementary Fig. 3b for results obtained in five other niPSCs. 
Representative images of 1 out of 3 independent experiments showing consistent results. k, Q-banding showing a normal karyotype in HPD01. Similar results 
were obtained in 7 out of 7 metaphases. See also Supplementary Fig. 3d. Scale bars, 50 µ m (c,h), 1 mm (g,j). Images from additional repeats for panels c,h and  
j have been deposited in Figshare under DOI: 10.6084/m9.figshare.7151801. See Supplementary Table 5 for all numerical values and P values.
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(Fig. 4a,b; Supplementary Fig. 5a). Consistent with the reduced 
levels of 5-methylcytosine (5mC), we observed decreased levels of 
the DNA methyltransferases DNMT3A and DNMT3B, a dramatic 
increase of the catalytically inactive DNMT3L, and of the 5mC 
oxidases TET1 and TET2 (Fig. 4c). We then determined the pat-
tern of genome methylation using reduced representation bisulfite 
sequencing (RRBS) in five niPSC lines, three fibroblasts from which 
they were derived and an isogenic primed iPSC line (Supplementary 
Table 1). The global methylation levels (Fig. 4d) and distributions 
(Supplementary Fig. 5b) of niPSCs were comparable to those of 
human blastocysts and other naive PSCs10,14,17. Unsupervised clus-
tering of the methylation pattern clearly separated naive PSCs from 
somatic cells and primed iPSCs (Fig. 4e). A set of promoters hypo-
methylated in human blastocysts compared to conventional primed 
human ESCs21,22 were found to be highly methylated in somatic and 
primed pluripotent cells, but hypomethylated in niPSCs, which is in 
line with their naive identity (Fig. 4f).
Analysis of imprinted and X-linked genes status. DNA methyla-
tion is crucial for genomic imprinting, the phenomenon whereby 
either the maternal or paternal copy of a gene is expressed. A previ-
ous study14 reported that DNA methylation is lost at imprinted loci 
in embryo-derived naive human ESCs; therefore, we tested whether 
niPSCs would have the same defects. We analysed 67 bona fide 
imprinted loci, divided into the following 3 classes (Fig. 5a): pla-
cental, maternal and paternal. Placental loci, methylated in human 
oocytes and blastocysts, but not in somatic cells (blood)23, were 
hypomethylated in fibroblasts and remained so after reprogram-
ming. Maternally imprinted loci lost methylation only in niPSCs, 
as previously reported14, while a fraction (5 out of 8) of paternally 
imprinted loci surprisingly maintained methylation in all niPSCs 
(Fig. 5a,b). Loss of DNA methylation at the imprinted regions should 
result in the aberrant biallelic expression of the cognate transcripts. 
We interrogated RNA-seq data, taking advantage of annotated sin-
gle nucleotide polymorphisms (SNPs) in MEG3 mRNA, and found 
monoallelic expression in somatic cells and biallelic expression in 
all naive PSCs, in agreement with its reduced methylation (Fig. 5c).
Female naive pluripotent cells contain two active X chromo-
somes24, characterized by low levels of DNA methylation at CG-rich 
regions called CpG islands. CpG island methylation on the X chro-
mosome in female niPSCs was dramatically reduced (Fig. 5d) rela-
tive to female fibroblasts, and were comparable to levels observed in 
male cells. An analysis of SNPs on X-linked genes showed biallelic 
expression of several transcripts in female niPSCs (Fig. 5e). Finally, 
high XIST expression was detected in female niPSCs compared to 
male niPSCs and somatic cells (Fig. 5f), as previously reported for 
female naive pluripotent cells in vitro and in vivo24. These results 
indicate a reactivation of both X chromosomes in female niPSCs.
Naive iPSCs display high mitochondrial activity. Mitochondrial 
activity has been reported to be higher in both murine and human 
naive cells compared to their primed counterparts5,7. We measured 
the mitochondrial membrane potential by tetramethylrhodamine 
methyl ester (TMRM) staining and it was barely detectable in 
primed cells (Fig. 6a). Conversely, niPSCs displayed robust TMRM 
staining. Both niPSCs and reset H9 cells10 displayed increased 
mitochondrial transcripts compared to primed PSCs (Fig. 6b) and 
fibroblasts (Fig. 6c), as previously reported in murine PSCs25. We 
conclude that niPSCs display epigenetic and metabolic features con-
sistent with a naive pluripotent state.
Characterization of the differentiation potential of niPSCs. 
Recent reports have shown that some human naive PSC lines are 
lineage biased and fail to differentiate towards mature cell types26,27, 
thus limiting their use for disease modelling and developmental 
studies. We tested the differentiation potential of three isogenic 
niPSC lines (HPD01, HPD03 and HPD04) to gauge the techni-
cal variability of our reprogramming system. A primed iPSC line 
(HPD00) was included as a control. First, we applied three different 
monolayer differentiation protocols and found that all three niPSC 
lines expressed mesoderm and endoderm markers after 6 days of 
differentiation, while ectoderm markers were robustly expressed 
around day 12 (Fig. 7a). As expected, primed iPSCs differentiated 
faster (Supplementary Fig. 6a, top). Second, we performed embryoid 
body differentiation and detected the expression of multiple mark-
ers of the three germ layers at day 22 in all 3 niPSC lines (Fig. 7b; 
Supplementary Fig. 6b). Third, after 50 days of embryoid body dif-
ferentiation (Fig. 7c; Supplementary Fig. 6c), we detected compa-
rable levels of markers of mature cell types in all iPSC lines. Fourth, 
we directly tested the ability of niPSCs to form mature cell types, 
adapting protocols previously defined for primed PSCs. After 15 
days of a hepatic differentiation protocol28, we observed polygonal-
shaped hepatocyte-like cells expressing the mature markers CYP3A 
and HNF4A, while a neuronal differentiation protocol29 success-
fully generated cells positive for MAP2, TUJ1 and NeuN (Fig. 7d,e; 
Supplementary Fig. 7a,b). Finally, all differentiation assays were 
repeated with an independent niPSC line (HPD06) derived from 
HFFs (Supplementary Figs. 6 and 7). In summary, these results 
demonstrate that niPSCs are pluripotent, respond to differentiation 
cues and are able to form mature cell types.
The confined microfluidic environment promotes establishment 
of naive pluripotency. Initial attempts to generate niPSCs using 
mmRNA under CCC failed. We reinvestigated this approach with 
our optimized protocol (Fig. 8a), comparing microfluidic condi-
tions and CCC. The generation of niPSCs via microfluidics was 
robust (100% of channels contained colonies, with an efficiency 
of 3.7 ± 1.0% and 3.1 ± 0.4% for BJ and HFF-1 cells, respectively). 
Conversely, in CCC, only 25% of wells contained naive-like colo-
nies, with efficiency values of 0.2% and 0.04% for BJ and HFF-1 
cells, respectively. Interestingly, a mixture of colonies displaying 
primed and naive morphology emerged in CCC (Fig. 8b, blue and 
red circles), a phenomenon never observed in the microfluidic cul-
ture conditions. These results strongly indicate that the confined 
microfluidic microenvironment promotes the generation of naive 
iPSCs over primed iPSCs, and that the culture conditions used 
(that is, RSeT medium with feeder cells) facilitate the propagation 
of different pluripotent cell types (Supplementary Fig. 8). By add-
ing the FGF receptor inhibitor PD173074, we selectively eliminated 
primed-like iPSCs (Fig. 8c, right) and obtained a stable niPSC line 
(HPD05) transcriptionally comparable to other naive iPSCs and 
clearly distinct from primed PSCs (Figs. 3a–c and 8d,e).
To directly test whether the confined microenvironment pro-
motes reprogramming to the naive state, we generated microfluidic 
chips with channels of different heights, inside which we then repro-
grammed BJ fibroblasts. At the height of 200 µ m, used in all other 
experiments, we obtained colonies at high efficiency, and all colonies 
expressed both KLF17 and OCT4 (Fig. 8f; Supplementary Fig. 7c). 
Increasing the height caused a reduction in both the number of 
colonies and the percentage of double-positive colonies, indicating 
the presence of either primed or partially reprogrammed colonies. 
Finally, decreasing the channel height to 100 µ m caused a reduction 
in colony number, which is probably due to rapid exhaustion of the 
culture medium. We conclude that reprogramming to naive pluri-
potency is enhanced with an optimal spatial confinement.
Finally, we determined whether microfluidics could also promote 
the conversion of primed PSCs to naive pluripotency. We generated 
primed H9 human ESCs expressing NANOG and KLF2 (NK2) in a 
doxycycline-inducible manner, as previously reported10,11. Exposure 
to 2iL+ doxycycline led to the formation of naive colonies, with a 
fivefold increase when using microfluidic conditions compared to 
CCC (Fig. 8g). In contrast, no naive colonies were observed under 
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conditions promoting primed pluripotency (with FGF and KSR), 
even under microfluidic conditions. We conclude that a confined 
environment promotes the activation of the naive pluripotency net-
work, regardless of the starting cell type, but only in conditions sup-
porting naive pluripotency.
Discussion
Microfluidics enables the manipulation of cells in a confined envi-
ronment, whereby autocrine and paracrine factors are more concen-
trated8. The use of microfluidics facilitates the robust and efficient 
generation of naive iPSCs, reducing by several orders of magnitude 
the costs and number of somatic cells required. The efficiency of 
reprogramming in our system (3–5%) is substantially higher than 
those of other non-integrating methods for generating conventional 
human iPSCs30. We speculate that cells undergoing reprogramming 
release extracellular factors that support survival or cell fate transi-
tion. Identification of such factors could help improve the efficiency 
of reprogramming protocols under CCC.
Previous studies have reported the conversion of human somatic 
cells to naive pluripotency10,11,13, but they relied on secondary sys-
tems, viral vectors or required two rounds of reprogramming 
(OSKM followed by NK2) via an intermediate primed state. Our 
results show that it is possible to directly convert somatic cells to 
naive pluripotency through the transient transfection of OSKMN-
specific mmRNAs. While KLF2 has previously been used to con-
vert primed PSCs to naive pluripotency10,11,17, it was not included 
in our reprogramming cocktail because of the functional redun-
dancy between KLF4 and KLF2, as observed in murine cells31. 
Correspondingly, KLF4 expression has recently been used to con-
vert human primed PSCs to naive pluripotency19.
While this manuscript was under revision, two studies were 
published reporting the generation of naive iPSCs from somatic 
cells via the expression of OSKM using Sendai viruses19,20. In those 
studies, iPSCs generated in t2iLGöY (titrated 2iL plus the protein 
kinase C inhibitor Gö6983 and the ROCK inhibitor Y27632) or 
5iLAF (a cocktail of 5 inhibitors targeting GSK3, MAPK/Erk, BRaf, 
Src and ROCK, plus the cytokines LIF, Activin A and FGF2) media 
consistently displayed a transcriptome similar to embryo-derived 
naive PSCs and niPSCs (Fig. 3a,c; Supplementary Fig. 4a–c), with 
robust expression of naive markers such as KLF17, TFCP2L1 and 
DNMT3L. Conversely, the use of RSeT medium led to variable 
results: in one study19, iPSCs generated in RSeT were transcription-
ally similar to primed iPSCs (Fig. 3a,c), while in the other study20, 
iPSC lines displayed either a naive or an intermediate phenotype, 
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with heterogeneous expression of KLF17 (Supplementary Fig. 4b,c). 
In contrast, we used OSKMN-specific mmRNAs, microfluidic con-
ditions and RSeT and obtained niPSCs homogeneously expressing 
several naive markers (Fig. 2g,h; Supplementary Fig. 2a,b) and dis-
playing transcriptomes similar to other embryo-derived naive PSCs 
(Fig. 3a–c; Supplementary Fig. 4a). These disparate outcomes with 
RSeT medium may be due to other methodological parameters, 
such as the use of Sendai viruses versus mmRNAs, OKSM versus 
OKSMN, and CCC versus microfluidic conditions.
We compared RSeT, 2iLGo and 4iLA media during naive iPSC 
generation via microfluidics (Fig. 2b; Supplementary Fig. 1g) and 
observed similar efficiencies regarding the formation of iPSC colo-
nies positive for both KLF17 and OCT4. This result suggests that 
the confined environment promotes the acquisition of naive pluri-
potency and that this effect is dominant over media composition. 
Indeed, all three types of media facilitated the robust expansion 
of established niPSCs (Supplementary Fig. 8). To directly test the 
effect of the confined environment, we increased the height of the 
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microfluidic channels (Fig. 8f; Supplementary Fig. 7c) and per-
formed reprogramming under CCC rather than microfluidics. We 
observed that only in an optimally confined environment could we 
obtain a homogenous population of naive colonies at high efficiency 
(Fig. 8a–c). Interestingly, using both a higher channel height and 
CCC, we obtained a mixed population of primed- and naive-like 
colonies in RSeT (Fig. 8b), resembling the results reported in a pre-
vious study20. Thus, we argue that the confined microfluidic envi-
ronment is instructive for the induction of naive pluripotency, and 
that RSeT is a more permissive medium, which allows the forma-
tion and expansion of a range of different pluripotent phenotypes 
under CCC.
A recent study32 investigated the acquisition of naive pluripo-
tency with a secondary system of in vitro-differentiated fibro-
blasts bearing a doxycycline-inducible OSKM cassette. A naive 
transcriptome was observed after 20 days of reprogramming, and 
transgene-independent iPSCs were obtained at day 24. In contrast, 
our method appears more rapid, given that by day 15 naive iPSC 
colonies showed a naive transcriptome (Fig. 3a–c; Supplementary 
Fig. 4a) and a homogeneous protein expression profile of naive fac-
tors (Figs. 1f and 2g; Supplementary Fig. 2a,b), and could be readily 
expanded without further mmRNA delivery. Since the generation 
of primed iPSCs from fibroblasts with mmRNA was also faster 
than with Sendai virus12,30, we suggest that the rapid and efficient 
generation of naive iPSCs achieved in this study is attributable to 
the combination of mmRNA and microfluidic technologies. It will 
be interesting to exploit our system to study at high resolution the 
trajectories followed by somatic cells towards naive pluripotency. 
As a proof of principle, we performed bulk analyses on fibroblasts 
reprogrammed to either naive or primed pluripotency and observed 
a common initial phase followed by two divergent trajectories 
(Figs. 3d,e and 8h).
Chromosomal abnormalities in some naive PSCs have been 
reported14,17,18. Only two out of eight lines displayed a tetraploid 
fraction of cells after long-term expansion, which could be elimi-
nated by FACS. We conclude that our method allows the genera-
tion of karyotypically normal naive PSCs, possibly due to the use 
of mmRNAs, which have been shown to cause the lowest number 
of chromosomal abnormalities compared to other non-integrat-
ing methods30. We argue that the prolonged expansion in culture, 
together with some yet unknown factors, might negatively influence 
genomic stability.
In conclusion, we showed that the confined microfluidic envi-
ronment strongly enhances the direct conversion of somatic cells 
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to naive pluripotency. With our technology, transgene-free niPSCs 
could be efficiently generated from patients, and their high clono-
genic capacity will allow efficient gene editing. Conventional PSC 
lines display strong differentiation biases6 and retain some somatic 
epigenetic features33. We provided evidence of prompt differen-
tiation capacity; however, it is still an open question as to whether 
naive PSCs could represent a better system for the generation of 
differentiated cell types for therapeutic purposes or for disease 
modelling. Furthermore, naive PSCs represent a good model sys-
tem to study early development, as exemplified by a recent study24 
of X-chromosome inactivation dynamics. Future studies compar-
ing the epigenetic profile and differentiation potential of multiple 
patient-specific niPSCs and conventional primed iPSCs will reveal 
the full potential of human niPSCs in regenerative medicine, disease 
modelling and developmental studies.
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Methods
Cell culture. Naive human ESCs (reset H9; described previously10, generated via 
the transient expression of NK2 and provided by A. Smith’s Lab) were cultured 
on mitotically inactivated mouse embryonic fibroblasts (MEFs; DR4, American 
Type Culture Collection) in 2iLGo medium prepared as follows: 1% N2 and 
2% B27 supplements in DMEM-F12:Neurobasal medium (N2B27, all Thermo 
scientific) were supplemented with 1 μ M PD0325901 (Axon Medchem), 1 μ M 
CHIR99021 (Axon Medchem), 10 ng ml−1 human LIF (produced in-house) and 
1–2 μ M Gö6983 (Axon Medchem). It was critical to titrate the concentration of 
each batch of Gö6983 to minimize cell stress due to accumulation of the inhibitor 
and to maximize the expression of naive markers. niPSCs were also generated and 
cultured on MEFs in the naive-supporting media 4iLA and RSeT. 4iLA medium 
was prepared as follows: N2B27 supplemented with 1 μ M PD0325901, 1 μ M WH-4-
023 (Axon Medchem), 0.5 µ M SB590885 (Axon Medchem), 10 µ M ROCK inhibitor, 
10 ng ml−1 LIF and 20 ng ml−1 activin-A. The FGF-free medium RSeT (05970, 
StemCell Technologies) was prepared following the manufacturer’s instructions. 
niPSCs were passaged every 4–6 days as follows: cells were washed with phosphate 
buffer without Ca2+/Mg2+ (PBS) and incubated with 300 µ l TripLE select (Thermo 
Scientific) per 12-well plate for 3 min at room temperature. N2B27 medium (700 µ l) 
was added to inhibit dissociation. Clusters (3–5 cells) were obtained by pipetting 
the entire volume twice. Cell suspensions were centrifuged at 300 × g for 4 min, 
resuspended in naive medium with 10 μ M of the ROCK inhibitor Y27632 (Axon 
Medchem) and seeded at ~300 MEFs per mm2. The ROCK inhibitor was used only 
for 24 h after passaging. The HFF cell lines BJ (passage 12) and HFF-1 (passage 18) 
(American Type Culture Collection), the female lung fibroblast cell lines WI-38 
and IMR-90 (American Type Culture Collection), and primary skin fibroblasts 
of an 80-year-old female donor were cultured in DMEM with 10% fetal bovine 
serum (FBS; Sigma-Aldrich) before reprogramming. Somatic cells were cultured in 
normoxia (21% O2, 5% CO2, 37 °C), whereas pluripotent stem cells were cultured in 
hypoxia (5% O2, 5% CO2, 37 °C); the medium was changed daily. All cell lines were 
mycoplasma-negative (Mycoalert, Lonza). Low passage and karyotipically normal 
primed human ESCs (H9; also known as WA09) were obtained from and used 
under authorization from WiCell Research Institute. Primed human ESCs and 
iPSCs (HPD00) were cultured on Matrigel-coated (Corning) conventional plates in 
mTeSR1 medium (StemCell Technologies).
Microfluidic chips production. Microfluidic chips were produced as described at 
Nature Protocol Exchange (https://doi.org/10.1038/protex.2018.083). The standard 
height of each channel is 200 µ m and the area is 27 mm2. Each channel holds 10 µ l  
of medium when considering the inlet, the outlet and the culture channel itself 
(Supplementary Fig. 1a).
Reprogramming. A detailed protocol for the generation of niPSCs via 
microfluidics has been shared at Nature Protocol Exchange (https://doi.
org/10.1038/protex.2018.083). All reprogramming experiments were performed 
in hypoxia conditions unless stated otherwise. Transfection of mmRNA leads 
to the transient production of the proteins of interest, with a peak between 12 
and 24 h, and complete clearance at 42 h12. Thus, to guarantee stable protein 
expression, we transfected cells daily. Moreover, for analyses of primary colonies by 
immunofluorescence, quantitative PCR (qPCR) or RNA-seq, we waited at least 3 
days since the last round of transfection to allow full clearance of the mmRNAs.
Microfluidic channels were coated with 25 µ g ml−1 fibronectin (Sigma-Aldrich) 
for 30 min at room temperature and fibroblasts were seeded at day − 1 at 25 cells 
per mm2 in DMEM/10% FBS. Of note, a density of 10 cells per mm2, optimal for 
the generation of primed iPSCs8, did not lead to the generation of niPSCs. On day 
0, 2 h before the first mmRNA transfection, we applied a medium optimized for 
mRNA transfection and previously used for the derivation of primed PSCs (PRM, 
StemMACS ReproBREW XF, Miltenyi Biotec). Where indicated, we added the 
ROCK inhibitor (5 μ M) and CHIR99021 (1 μ M) to the PRM. Cells were transfected 
daily at 9:00, and fresh PRM was given daily at 18:00. From day 6, we used a naive-
supporting medium with the same regimen of transfection and fresh medium 
change. From days 0 to 12, media were supplemented with 200 ng ml−1 B18R 
(eBioscience) to suppress single-strand-RNA-induced immune responses. The 
transfection mix was prepared according to the StemMACS mRNA transfection 
kit (Miltenyi Biotec): 100 ng μ l−1 mmRNA mix of OSKMN and nuclear green 
fluorescent protein (with stoichiometry 3:1:1:1:1:1) was diluted in transfection buffer 
by mixing 10 µ l of the mmRNA mix with 30 µ l of the buffer. Transfection reagent was 
diluted separately in transfection buffer by mixing 3 µ l of the transfection reagent 
with 37 µ l of the transfection buffer. The two solutions were mixed (final volume of 
80 µ l) and incubated for 20 min. For each microfluidic channel, we diluted 1.2 µ l of 
the transfection solution in 8.8 µ l of medium (either PRM or naive medium) and 
added it to the cells (corresponding to 0.28 ng mm−2). During the first 6 days, the 
dose of mmRNAs was gradually increased to facilitate expansion of fibroblasts.
For reprogramming in wells (CCC), we used the conditions described for 
microfluidics but increased the amount of mmRNA. For each well of a 12-well 
plate, we used 46.3 µ l of transfection solution in 0.8 ml of medium, which 
corresponds to 1.5 ng mm−2.
Reprogramming of fibroblasts towards the primed state via microfluidics was 
achieved using the protocol described above, but using PRM until day 12. To allow 
direct comparison of the reprogramming trajectories towards primed and naive 
pluripotency (Fig. 3d–f), we used the same seeding density of 25 cells per mm2 and 
the same OSKMN mmRNA cocktail.
For testing the effect of different microfluidic channel heights (Fig. 8f), the 
same mmRNA amount per cell was delivered daily, independently of the  
channel heights.
Resetting of primed H9 cells to naive was performed as described previously10. 
In brief, primed H9 cells were transfected with doxycycline-inducible NK2 
piggyBac constructs on MEF feeders in DMEM-F12 supplemented with 20% KSR 
(Gibco) and 10 ng ml−1 bFGF (produced in-house). After selection, cells were 
dissociated into single cells with TrypLE and replated on day − 2 in the presence 
of the ROCK inhibitor for 24 h in microfluidic conditions and CCC at a density 
of 4 cells per mm2. Medium was changed daily for CCC and twice a day for 
microfluidic conditions. On day − 1, cells were incubated with doxycycline  
(1 µ g ml−1; Thermo Scientific). From day 0, the medium was switched to 2iL where 
indicated. On day 14, cells were fixed and stained with an anti-TFCP2L1 antibody.
In vitro differentiation. For germ layer differentiation, niPSCs were seeded on 1% 
Matrigel-coated coverslips with 100 MEFs per mm2 and cultured in RSeT medium 
for 2 days. Germ layer-specific medium was used thereafter, with daily medium 
changes. Ectoderm medium was used for 12 days, mesoderm medium was used for 
6 days and endoderm medium was used for 6 days. Ectoderm medium consisted 
of knockout DMEM (Thermo Scientific), 15% KSR, 1% non-essential amino acids 
(NEAA), 1% L-glutamine, 0.1 µ M LDN193189 (Miltenyi Biotec) and 20 ng ml−1 
hFGF2 (PeproTech); after the first 3 days, hFGF2 was replaced with  
10 µ M SB431542 (Miltenyi Biotec) for 9 days. Mesoderm medium consisted of 
RPMI with 2% B27 (Thermo Scientific), 20 ng ml−1 hFGF2, 50 ng ml−1 hBMP4 
(R&D) and 3 µ M CHIR99021 (only for the first 2 days). Endoderm medium 
consisted of RPMI with 2% B27, 100 ng ml−1 activin-A (PeproTech) and 3 µ M 
CHIR99021 (only for the first 2 days). For embryoid body culture, niPSC colonies 
were mechanically scratched with a tip and transferred into ultra-low adhesive 
wells (Corning) in the presence of DMEM, 20% FBS, 200 mM L-glutamine, 1% 
NEAA and 0.1 mM 2-mercaptoethanol8. Medium was changed every other day for 
15 days before plating the embryoid bodies onto 1% Matrigel-coated glass plates 
(Labtek). After 5 days, adherent and spread cells were fixed for immunostaining.
Neuronal differentiation. The neuronal differentiation protocol was adapted 
from a previously published protocol29. Naive iPSCs were seeded as single cells at 
high density (530 cells per mm2) on Matrigel-coated plates. Cells were cultured for 
2 days in RSeT. On day 0, cells were cultured in N2B27, 1% NEAA, 200 ng ml−1 
L-ascorbic acid (neural medium) supplemented with 20 ng ml−1 bFGF and 0.1 µ M  
LDN193189. Medium was refreshed daily. On day 3, medium was switched to 
neural medium supplemented with 0.1 µ M LDN193189 and 10 µ M SB431542. On 
days 4–9, the same medium was supplemented with 1 μ M all-trans retinoic acid 
(Sigma-Aldrich) and 1 μ M SAG (Calbiochem) and was refreshed daily. On days 
10–15, medium was switched to neural medium supplemented with 5 μ M DAPT 
(Sigma-Aldrich) and 4 μ M SU-5402 (Sigma-Aldrich), 1 μ M all-trans retinoic acid 
and 1 μ M SAG (Smoothened Agonist, Calbiochem), and was refreshed daily. On 
day 16, cells were dissociated with TrypLE for 10 min, and 2 volumes of neural 
medium was added to inhibit dissociation. Cells were seeded on Matrigel-coated 
glass coverslips in wells and cultured in maturation medium, which is based on 
neural medium supplemented with 20 ng ml−1 BDNF, 10 ng ml−1 GDNF, 10 ng ml−1 
CNTF (PeproTech) and 10 μ M of the ROCK inhibitor for the first 24 h. Fresh 
maturation medium was provided daily up to day 22 when cells were fixed for 
immunostaining.
Hepatic differentiation. The hepatic differentiation protocol was adapted from 
a previously published protocol28. Briefly, niPSCs were seeded as single cells 
(20 cells per mm2) on Matrigel-coated plates with sparse MEF coverage (50 cells 
per mm2). Cells were cultured for 2 days in RSeT. On day 0, cells were cultured 
in RPMI, 2% B27 and 3 µ M CHIR99021. The same medium with the addition of 
100 ng ml–1 activin-A was refreshed on days 1–2. On days 3–8, the medium was 
switched to knockout DMEM with 20% KSR, 2 mM L-glutamine, 1% NEAA, 
0.1 mM 2-mercaptoethanol and 1% dimethylsulfoxide (DMSO), and changed 
every other day. On days 9–15, cells were cultured in maturation medium, which 
is based on L15 basal medium, 8% FBS, 8% tryptose phosphate broth (Sigma), 
10 µ M hydrocortisone (Sigma), 1 µ M insulin, 2 mM L-glutamine, 10 ng ml−1 HGF 
(PeproTech) and 20 ng ml−1 oncostatin-M (PeproTech). Fresh maturation medium 
was provided every other day.
Immunofluorescence and stainings. Immunofluorescence analysis was performed 
either on 1% Matrigel-coated glass coverslips in wells or in situ in microfluidic 
channels with the same protocol. Cells were fixed in 4% (w/v) paraformaldehyde 
(Sigma-Aldrich) in PBS for 10 min and blocked in 5% horse serum with 0.3% (v/v) 
Triton-X-100 (Sigma-Aldrich) for 1 h. Blocking buffer:PBS (1:2) was used to dilute 
primary antibodies (Supplementary Table 3). For staining for 5mC, fixed samples 
were permeabilized with 0.5% Triton X-100 for 1 h and treated with 2 N HCl for 
30 min at room temperature to denature DNA. Samples were neutralized with PBS 
before blocking and antibody incubation. Secondary antibodies (Supplementary 
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Table 3) were incubated at room temperature for 45 min at 1:500. Nuclei were 
stained with either Hoechst 33342 (Thermo Scientific) or 4,6-diamidino-2-
phenylindole (DAPI; Sigma-Aldrich). For mitochondrial staining, cells were 
incubated with 1:50,000 TMRM and 1:20,000 MitoTracker (Thermo Scientific, 
T668, M7514) for 30 min in culture medium at 37 °C and washed twice in PBS 
before image acquisition. For EdU staining, cells were exposed to an EdU pulse 
of 1 h before fixation in formaldehyde for 15 min. Samples were processed using 
a Click-iT EdU Alexa Fluor 488 Imaging kit and counterstained with Hoechst 
nuclear dye (all Thermo Scientific). Fluorescence images were acquired using a 
Leica SP5 II confocal system or a Leica 6000B epifluorescence microscope. For 
alkaline phosphatase staining, cells were fixed with a citrate–acetone–formaldehyde 
solution and stained using an alkaline phosphatase kit (Sigma-Aldrich). Plates were 
scanned using an Epson scanner and scored manually.
Flow cytometry and cell sorting. Single cells in suspension were obtained by 
incubating samples for 5 min with TrypLE. For DNA content analysis by flow 
cytometry, cell pellets fixed in cold 70% ethanol were resuspended in PBS, 
incubated with 50 µ g ml−1 propidium iodide, and processed using a FACSCanto 
II (BD). For cell sorting based on DNA content, cells were resuspended in naive 
medium with 10 µ M of the ROCK inhibitor and 5 µ M Vybrant DyeCycle Ruby live 
stain (Thermo Scientific) for 30 min before sorting. Sorted samples were cultured 
on new MEFs with 10 µ M of the ROCK inhibitor for 24 h. See Supplementary  
Fig. 3c for the gating strategy.
Karyotyping. Cells were incubated with 0.06 μ g ml−1 KaryoMAX (Thermo 
Scientific) in culture medium for 6 h at 37 °C. niPSCs were isolated with ReLeSR 
(StemCell Technologies) and resuspended in PBS before centrifugation. The 
pellet was resuspended in pre-warmed 75 mM KCl for 10 min at 37 °C. After 
centrifugation, the pellet was gently resuspended in 1 ml of freshly prepared 
fixative (3:1 methanol:acetic acid). This step was repeated twice. Q-banded fixed 
samples were analysed by Research & Innovation.
qPCR. Total RNA was isolated using a Total RNA Purification kit (Norgen 
Biotek), and complementary DNA was made from 500 ng using M-MLV Reverse 
Transcriptase (Invitrogen) and dN6 primers. For real-time PCR, SYBR Green 
Master mix (Bioline, BIO-94020) was used. Primers are detailed in Supplementary 
Table 4. Three technical replicates were performed for all qPCR experiments. 
GAPDH was used as the endogenous control to normalize expression.
RNA-seq. niPSCs were isolated from MEFs using ReLeSR. Briefly, cells were 
washed with PBS and then incubated with ReLeSR for 60 s. ReLeSR was then 
removed and cells were left with a thin film of liquid for 7 min. N2B27 medium was 
added and pipetted 4–5 times to detach colonies. Total RNA was isolated as above 
and sequenced using an Illumina NexSeq500, in 75-base pair pair-end format. 
Libraries were prepared following standard protocols from Illumina using a TruSeq 
Stranded mRNA Library kit. Expression levels for all the genes from ENSEMBL 
87 were quantified using RSEM v.1.3.036 with STAR v.2.5.2b37 (human genome 
GRCh38.p7). We built the genome index for STAR alignment using “rsem-prepare-
reference” with options ‘–star-sjdboverhang’ set to mean read length minus 1 
according to STAR guidelines. Alignment and quantification were performed 
with default parameters using the stranded pair-end mode. The gene expression 
level quantification of 21 samples collected from publicly available datasets was 
performed as described for the in-house samples. The RSEM parameters were set 
according to the library design (mean reads length, stranded/non-stranded, paired/
single end; see Supplementary Table 2). We generated the final expression matrix 
excluding the genes that had less than 10 raw counts in at least 3 out of 34 samples. 
After applying this filter, we obtained the expression of 20,936 genes.
All RNA-seq statistical analyses were carried out in R environment (v.3.4.3) 
with Bioconductor 3.6. We computed the differentially expressed genes (DEGs) 
among the three groups (primed, naive, fibroblast) using edgeR38 (function call 
“fit = glmQLFit(counts, design= ~group); glmTreat(fit, coef= n, lfc= 2)” where 
‘n’ is one of the contrasts). A gene was considered a DEG when the absolute 
value of log2-fold change was > 2 and the adjusted P value was < 0.05 (p.adjust 
function, Benjamini–Hochberg method). Principal component analysis (PCA) 
was performed using log2-normalized pseudocounts (defined as count plus 1) 
with the prcomp function and default parameters using DEGs. Heatmaps were 
made using the log2-normalized pseudocounts (unless stated otherwise) with the 
pheatmap function from pheatmap R package (v.1.0.8, distance used ‘euclidean’, 
‘ward’ linkage, scale= ‘row’) on DEGs or selected markers. The raw counts were 
normalized using the betweenLaneNormalization function with the upper quantile 
method (EDAseq R package)39.
For the comparison between our RNA-seq dataset and the DGE-seq dataset20 
presented in Supplementary Fig. 4c, we first obtained expression values in UMI 
per million from Supplementary Data 1 of the other study20, while our dataset was 
transformed into transcripts per million. Both datasets were quantile-normalized 
and z-scored by row separately, as described in the other study20. We merged 
the two datasets via the gene identification number to obtain a single dataset 
containing 14,944 genes. PCA was computed using the 4,606 genes obtained from 
intersecting the merged dataset, and the DEGs used for the RNA-seq comparison 
in the PCA are shown in Fig. 3c.
Transposon analysis. Transposon coordinates were downloaded from UCSC 
repeat masker track (hg38). We filtered out those transposons that overlap any 
genomic features annotated in ENSMBL 87. We aligned the raw reads using 
bowtie2 sensitive and end-to-end mode on the human genome GRCh38.p7. 
Transposon expression was quantified using bamtools multicov (v.2.26.0).
We analysed transposons with at least 20 counts per million in at least one 
sample. Differentially expressed transposons were identified using the edgeR R 
package. A transposon was considered differentially expressed when the P value 
was ≤ 0.05 and the log2-fold change was ≥ 2. Heatmaps were made using the  
log2-normalized pseudocounts scaled by row means with the pheatmap R package 
as describe for the RNA-seq data.
SNP analysis for imprinting and X reactivation. From the alignments, we 
extracted the reads with a minimum quality of 30 (samtools view –q 30 align.bam 
align-f.bam). Using GATK haplotypeCaller (genotyping_mode: DISCOVERY, 
minReadsPerAlignmentStart: 5, max_alternate_alleles: 1, stand_conf_call: 1 and 
filter_reads_with_N_cigar), we generated allele counts over the SNPs of dbSNP 
human v.b149. Non-biallelic variants as well as insertions and deletions were 
filtered out. Moreover, we considered only SNPs with at least ten reads in at least 
one sample. A SNP was considered heterozygous when the ratio of the counts 
between minor and major alleles was greater than 0.2 and the minor allele had at 
least 5 reads. A minor allele is the allele with fewer counts.
The loss of imprinting of a gene was quantified as the number of SNPs that 
showed heterozygosity in each gene. We called a loss of imprinting when at 
least two SNPs showed heterozygosity in a gene. X reactivation was quantified 
by selecting the heterozygous SNP from X-chromosome genes and by plotting 
the minor/total allele count ratios of heterozygous SNPs (defined as above). 
We excluded the pseudo-autosomal regions (PAR1: chrX:10,000–2,781,479 
and chrY:10,000–2,781,479; PAR2: chrX:155,701,383–156,030,895 and 
chrY:56,887,902–57,217,415) from the analysis.
Methylation analysis. RRBS libraries were produced using an Ovation 
RRBS Methyl-Seq System (NuGEN) starting with 100 ng of genomic DNA 
extracted with a Quick-DNA Plus kit (Zymo) according to the manufacturer’s 
specifications. Libraries were sequenced on a NextSeq 500 (Illumina) using a 
single-end 75-cycle high-output flow cell. Sequence reads were first trimmed 
using Trim Galore software (v.0.4.1, Babraham Bioinformatics, available at 
www.bioinformatics.babraham.ac.uk/projects/trim_galore/) to remove adapter 
sequences and low-quality end bases and then trimmed with a custom python 
script provided by NuGEN Technical Support (v.1.11) to remove any read that 
did not contain an MspI site signature (YGG) at the 5′ -end. Alignment of the 
reads onto the hg19 reference sequence and methylation calling were performed 
using Bismark40(v.0.18.1). Coordinates of differentially methylated regions were 
obtained from the literature21,23. Subsequently, average DNA methylation levels 
and total coverage for each differentially methylated region were determined 
for all Bismarck-processed RRBS data files using R (v.3.3.3) and the methylkit 
package (v.0.9.5)41. To that end, RRBS data files were processed with the methRead 
function and the bismarkCoverage parameter set. Next, the regionCounts function 
was used to determine the number of methylated and unmethylated C residues 
in each of the differentially methylated regions in each sample. These values were 
then combined using the unite() function with the min.per.group paramater set 
to 1. Finally, we only retained those regions that were covered by at least five reads 
and computed a coverage weighted average methylation level for each region 
across all CpG islands that were covered. These values are plotted in Fig. 4d–f 
and listed in Supplemenary Table 5 along with the genomic coordinates of each 
genomic region on hg19.
Image analyses. Fiji 1.0 (ImageJ2) was used for image analyses. The size 
of niPSC colonies (Fig. 2d) was measured by delimiting a colony area and 
calculating the equivalent diameter as (area/π )0.5 (using the Shape filter plugin 
function). Fluorescence intensity (H3K9me3 or 5mC) across nuclei (Fig. 4a,b; 
Supplementary Fig. 5a) was measured using the Plot Profile function. For each 
cell line, we selected representative fields and six nuclei were randomly chosen as 
described previously10.
Statistics and reproducibility. For statistical analyses, normality distribution was 
tested using D’Agostino–Pearson normality tests in Prism (Graphpad). The non-
parametric Kruskal–Wallis test was used with non-normal datasets, using Dunn’s 
correction for multiple comparisons. For datasets with n = 3 normality distribution 
and for which variance could not be estimated, we used the non-parametric two-
tailed Wilcoxon Mann–Whitney U-test, for which the asymptotic P values were 
calculated in R to avoid continuity correction. Tests and exact P values are reported 
in Supplementary Table 5. The numbers of replicates and independent experiments 
are indicated in the figure legends and in Supplementary Table 5, which reports the 
numerical values for all technical replicates of each dataset in this study. All error 
bars indicate the standard error of the mean (s.e.m.). All qPCR experiments were 
repeated at least two times independently, with three technical replicates for each 
experiment. All key experiments were repeated independently using different cells 
lines (for example, reprogramming of five different somatic cell types, molecular 
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characterization of five niPSC lines and differentiation of four different niPSC 
lines). For reprogramming experiments under CCC, we performed at least two 
independent experiments, while for microfluidic experiments, we performed up to 
eight independent experiments, with 5–60 technical replicates. All differentiation 
experiments were performed in at least two biologically independent experiments, 
using between two and four different niPSCs lines. For RNA-seq and RRBS, we 
profiled at least five niPSC lines together with relevant controls.
Reporting Summary. Further information on research design is available in the 
Nature Research Reporting Summary linked to this article.
Data availability
RNA-seq and RRBS data of this study have been deposited in the Sequence Read 
Archive (SRA) under BioProject number PRJNA381757 and GEO under accession 
code GSE110377. Accession numbers of other published datasets are reported in 
each figure plotting RNA-seq data and in Supplementary Table 2. Source data of all 
repeats of all experiments are provided in Supplementary Table 5. For figure panels 
showing representative images of morphologies or immunostainings, images from 
additional independent repeats are available at Figshare (https://doi.org/10.6084/
m9.figshare.c.4250195). All other data supporting the findings of this study are 
available from the corresponding author upon reasonable request.
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Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main 
text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement
An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one- or two-sided 
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested
A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons
A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND 
variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Give P values as exact values whenever suitable.
For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings
For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes
Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated
Clearly defined error bars 
State explicitly what error bars represent (e.g. SD, SE, CI)
Our web collection on statistics for biologists may be useful.
Software and code
Policy information about availability of computer code
Data collection For qPCR data collection the Applied Biosystems™ QuantStudio™ 6 Flex Real-Time PCR System version 1.3 was used. 
For immunostaining data collection the Leica TCS SP5 LAS AF version 2.7.3.9723 was used, and Leica 6000B LAS AF version 2.7 was used 
for tiling of entire microfluidics channels. 
For flow citometry and cell sorting data collection the BD FACSCanto™ II FACSDiva version 6.1.3 and the Bio-Rad S3e™ Cell Sorter   
ProSort™ version 1.4.0.20 were used.
Data analysis For statistical analysis we used Prism 6 (Graphpad, version 6.05).  
Fiji 1.0 (ImageJ2) was used for image analysis. 
 
For RNA-Seq data analysis, expression levels for all the genes from ENSEMBL 87 were quantified using RSEM 1.3.0 (RNA-Seq by 
Expectation-Maximization) with STAR 2.5.2b (RNA-Seq aligner). All RNA-seq statistical analyses were carried out in R environment 
(version 3.4.3) with Bioconductor 3.6. We computed the differentially expressed genes (DEG) among the 3 groups (primed, naïve, 
fibroblast) using edgeR. Principal component analysis (PCA) was performed using log2-normalized pseudo-counts (defined as count plus 
1) with prcomp function with default parameters using DEGs. Heatmaps were made using the log2-normalized pseudo-counts (unless 
stated otherwise) with pheatmap function from pheatmap R package (version 1.0.8), distance used ‘euclidean’, ‘ward’ linkage, 
scale=’row’) on DEGs or selected markers. The raw counts were normalized using betweenLaneNormalization function with upper 
quantile method (EDAseq R package). 
We provide in Supplementary Table 5 (Statistic Source Data) all the values used to build heatmaps and PCAs. 
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SNP analysis was performed using  GATK haplotypeCaller version 3.8-0-ge9d806836 (genotyping_mode: DISCOVERY, 
minReadsPerAlignmentStart: 5, max_alternate_alleles: 1, stand_conf_call: 1 and filter_reads_with_N_cigar). 
 
Libraries generated in RRBS were analysed as follow: sequence reads were first trimmed using Trim Galore software (Version 0.4.1) to 
remove adapter sequences and low-quality end bases and then trimmed with a custom python script provided by NuGEN Technical 
Support (Version 1.11) to remove any read that does not contain an MspI site signature (YGG) at the 5’-end. Reads alignment on hg19 
reference sequence and methylation calling was then performed with Bismark (Version 0.18.1_dev ). Coordinates of DMRs were 
obtained from literature. Subsequently, average DNA methylation levels and total coverage for each DMR region was determined for all 
Bismarck processed RRBS data files using R (Version 3.3.3) and the methylkit package (version 0.9.5). To that end, RRBS data files were 
processed with the methRead function and the bismarkCoverage parameter set. Next, the regionCounts function was used to determine 
the number of methylated and unmethylated C’s in each of the DMRs in each sample. These values were then combined using the unite()  
function with the min.per.group paramater set to 1.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers 
upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data
All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: 
- Accession codes, unique identifiers, or web links for publicly available datasets 
- A list of figures that have associated raw data 
- A description of any restrictions on data availability
All RNA-seq and RRBS data generated in this study can be found in SRA Accession number: PRJNA381757  
Repository/DataBank Accession: GEO  
Accession ID: GSE110377  
Databank URL: https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE110377 
Additional images from indepedent repeats of morphological analyses and immunostainings on Figshare Collection “Generation of human naive induced pluripotent 
stem cells in microfluidics” ( 10.6084/m9.figshare.c.4250195 ). 
Field-specific reporting
Please select the best fit for your research. If you are not sure, read the appropriate sections before making your selection.
Life sciences Behavioural & social sciences  Ecological, evolutionary & environmental sciences
For a reference copy of the document with all sections, see nature.com/authors/policies/ReportingSummary-flat.pdf
Life sciences study design
All studies must disclose on these points even when the disclosure is negative.
Sample size Sample size calculation was not performed. Sample size was chosen based on standards in the field and is indicated in figure legends and in 
Supplementary Table 5, which reports all source data for each dataset in this study. All qPCR experiments have been repeated at least two 
times independently, with 3 technical replicates for each experiment. All key experiments were repeated independently using different cells 
lines (e.g. reprogramming of 5 different somatic cell types, molecular characterization of 5 niPSC lines and differentiation of 4 different niPSC 
lines). For reprogramming experiments under conventional condition we performed at least two independent experiments, while for 
microfluidic experiments we performed up to 8 independent experiments, with 5 to 60 technical replicates. All differentiation experiments 
were performed at least in two biologically independent experiments, using between 2 and 4 different niPSCs lines. For RNAseq and RRBS we 
profiled at least 5 niPSC lines together with relevant controls. 
Data exclusions We presented all data obtained, also in the case of negative results.
Replication The main findings, such as the reprogramming of somatic cells to naive pluripotency, have been reproduced with n>400.  
For qPCR at least 2 independent experiments have been performed and confirmed by independent techniques (e.g. RNAseq in Fig. 3a, 
immunostaining in Fig. 2g-h and Supplementary Fig. 2 and qPCR for pluripotency markers in Fig. 2e-f).  
For RNA-seq and RRBS we analysed 5 independently generated niPSC lines, together with relevant controls.
Randomization Randomization was not relevant. All cell lines or biological samples were analysed or treated in the same manner. 
Blinding Blinding was not applicable to reprogramming and differentiation assays, but comparable results were obtained by two distinct operators in 
two different laboratories. We applied blinding for RNA-seq processing and data analysis. 
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Materials & experimental systems
n/a Involved in the study
Unique biological materials
Antibodies
Eukaryotic cell lines
Palaeontology
Animals and other organisms
Human research participants
Methods
n/a Involved in the study
ChIP-seq
Flow cytometry
MRI-based neuroimaging
Antibodies
Antibodies used Please see Supplementary Table 3 for the list of antibodies, product codes, dilutions used for immunostaining and validation 
from literature.
Validation Antibodies were used following manufacturers guidelines and were validated in our laboratory by using negative or positive 
controls. For instance when appropriate naive, primed or differentiated pluripotent stem cells were used. Finally, the antibodies 
selected for this work have been previously used in literature. 
Eukaryotic cell lines
Policy information about cell lines
Cell line source(s) MEF DR4, BJ and HFF-1 human foreskin fibroblasts, WI-38 and IMR-90 female lung fibroblasts were obtained from ATCC.  
H9 (WA09) human ES cells were obtained from WiCell. 
The Reset H9 described in Takashima were kindly provided by Austin Smith's laboratory.  
Primary Human Dermal Fibroblasts were kindly provided by Professor Vindigni at University of Padua.
Authentication H9 human ES cells were authenticated by STR profiling by WiCell. 
MEF DR4, BJ, HFF-1, WI-38 and IMR-90 were authenticated by STR profiling by ATCC. 
Reset H9 cells were authenticated in this study by SNP profiling together with a panel of niPSCs and primed iPSCs generated 
in this study (HPD00, HPD01, HPD03, HPD04, HPD06, HPD08).   
Mycoplasma contamination Cells were routinely tested for Mycoplasma contamination. All cell lines were Mycoplasma negative.
Commonly misidentified lines
(See ICLAC register)
The cell lines used are not listed in ICLAC.
Flow Cytometry
Plots
Confirm that:
The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology
Sample preparation Single cells in suspension were obtained by incubating samples for 5 min with TrypLE. For DNA-content analysis by flow 
cytometry, cells pellets fixed in cold 70% ethanol were resuspended in PBS, incubated with 50 μg ml-1 propidium iodide, and 
processed with FACSCanto II (BD). For cell sorting based on DNA-content, cells were resuspended in naïve medium with 10 μM Ri 
and 5 μM Vybrant DyeCycle Ruby live stain (Thermo Scientific) for 30 min before sorting and sorted at S3e sorter (Bio-rad). 
Sorted samples were cultured on new MEFs with 10 μM Ri for 24 h.
Instrument FACSCanto II (BD) and S3e sorter (Bio-rad)
Software FACSDiva version 6.1.3 and ProSort™ version 1.4.0.20 
Cell population abundance We sorted 2000 diploid HPD01 cells in Supplementary Fig. 3c. Reanalysis after 6 passages after Propidium Iodide staining 
indicated a pure diploid population.
Gating strategy We stained diploid primed H9 hES cells (WiCell) with Vybrant DyeCycle Ruby, in order to set the gate on the G1 fraction. Such 
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Gating strategy gate was used to sort diploid HPD01 cells from a mixed population of diploid and tetraploid cells.  
See Supplementary Fig. 3c bottom panel for exemplification of the gating strategy.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
